LIGAND PHARMACEUTICALS INCORPORATED Interest Receivable
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Interest Receivable of $200.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Balance Sheet › Assets
us-gaap:InterestReceivable · last filed 2026-05-08
- 2026-03-31: Interest Receivable $200.00K.
- 2025-12-31: Interest Receivable $100.00K.
| Period end | Interest Receivable |
|---|---|
| 2026-03-31 | $200.00K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $100.00K 10-K · filed 2026-02-27 |